DB05525InvestigationalGene Therapies
EW-A-401 is a circle of genetic material (plasmid DNA) that instructs the body to produce a genetically-engineered transcription factor, a protein that regulates expression of genes. This specific transcription factor... This specific transcription factor has been shown in animal studies to increase expression of the VEGF-A gene, and to promote the growth of new blood vessels.
- Primary indication
- Investigated for use/treatment in peripheral vascular disease.Curator reviewed
- Also known as
- EW-A-401 DNA Plasmid Vector
- Code names
- EW-A-401
What you can answer from here — as of April 02, 2025
Which companies are running trials of EW-A-401, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account